CabaGast starts recruting

This multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach is currently recruiting participiants.

Dr. Harald Schmalenberg (University hospital Jena) is the coordinating investigator.

More information about this study my be obtained under the rubric "studies" or here.